Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Grant

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Diabetes Care|January 1, 1996
The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetesP J Grant
Heart (British Cardiac Society)|January 30, 2009
Thiazolidinediones and cardiovascular outcomes in type 2 diabetesP J Grant
Circulation|December 13, 1997
Plasminogen activator inhibitor-1 gene and myocardial infarctionP J Grant
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 16, 1998
Polymorphisms of coagulation/fibrinolysis genes: gene environment interactions and vascular riskP J Grant
Hospitals|June 1, 1977
Zero base budgeting and the planning processP J Grant
Diabetes & Vascular Disease Research|April 7, 2010
Diabetes and the vulnerable plaque: putting the tail on the donkeyP J Grant
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1990
Hormonal regulation of the acute haemostatic response to stressP J Grant
Thrombosis and Haemostasis|July 31, 1998
Metformin reduces circulating factor VII concentrations in patients with type 2 diabetes mellitusP J Grant
Journal of Internal Medicine|July 25, 2007
Diabetes mellitus as a prothrombotic conditionP J Grant
Current Medical Research and Opinion|April 7, 2005
Inflammatory, atherothrombotic aspects of type 2 diabetesP J Grant
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Diabetes Care|January 1, 1996
The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetesP J Grant
Heart (British Cardiac Society)|January 30, 2009
Thiazolidinediones and cardiovascular outcomes in type 2 diabetesP J Grant
Circulation|December 13, 1997
Plasminogen activator inhibitor-1 gene and myocardial infarctionP J Grant
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 16, 1998
Polymorphisms of coagulation/fibrinolysis genes: gene environment interactions and vascular riskP J Grant
Hospitals|June 1, 1977
Zero base budgeting and the planning processP J Grant
Diabetes & Vascular Disease Research|April 7, 2010
Diabetes and the vulnerable plaque: putting the tail on the donkeyP J Grant
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1990
Hormonal regulation of the acute haemostatic response to stressP J Grant
Thrombosis and Haemostasis|July 31, 1998
Metformin reduces circulating factor VII concentrations in patients with type 2 diabetes mellitusP J Grant
Journal of Internal Medicine|July 25, 2007
Diabetes mellitus as a prothrombotic conditionP J Grant
Current Medical Research and Opinion|April 7, 2005
Inflammatory, atherothrombotic aspects of type 2 diabetesP J Grant
Pageof 21